Elevate: Solve. Architect. Build.
When commercial readiness lags the science, launches stumble, payers don't move, and patients wait longer than they should. Not because the science isn't there. Because the infrastructure underneath it wasn't built in time.
We built ElevEx BioGroup to close that gap; from the inside, not from a slide deck. We work alongside founder-led, PE and VC-backed companies where the margin for error is smallest and the timeline never moves in your favor.
Science is moving faster than commercial readiness. That gap doesn't close on its own.
HOW IT USUALLY STARTS
A familiar problem. A conversation.
Then we get to work.
Every engagement begins with a conversation about where you are, what you're building, and what's standing between you and the outcome that matters.
You're Not Launch Ready
01
You're 12 to 18 months from launch and the commercial infrastructure isn't fully built.
The plan exists. The team and systems to execute it don't yet.
Payers Aren't Moving
Your market access strategy looks good on paper but hasn't been stress-tested with payers.
02
Assumptions made early surface late. Usually at the worst possible moment.
Growth Has Outpaced the Model
The operating model that got you here isn't built for where you're going.
What worked at Series B isn't holding up post-approval or post-acquisition.
03
You Need Senior Expertise Now
You need a senior commercial voice in the room now, not after a six-month search.
The next 90 days matter too much to wait.
04
When The Phone Rings
These are the conversations that start it.
No two engagements begin the same way.
But the pressure behind them always sounds familiar.
01
We just closed Series C and our board wants a launch plan by Q3.
We don't have a commercial team yet.
02
Our VP of Commercial just left. Launch is 90 days out.
We can't pause.
03
We've been told our payer strategy is solid but we're getting pushback in every meeting. Something isn't working.
04
We just acquired a company and the integration is a mess. Two CRMs, two field forces, nobody trusts the numbers.
05
We're in a category that's never existed.
There is no playbook for what we're trying to do.
Market Access
Payers decide before launch. Most companies plan after it.
We don't advise on payer conversations. We've been in them. Market landscape strategy built backward from the coverage decision. Evidence designed to win coverage, not just to exist. That sequencing has to start years before launch.
Transformation
We're growing faster than our infrastructure can handle.
The bodyshops send robots with a transformation playbook. We send people who have been inside the wreckage. Operating model redesign. M&A integration. Workforce optimization. We fix what's broken. We build what was never there. We don't slow down what's working.
We don't advise on launch infrastructure. We've built it; in categories with no playbook, on timelines that never moved in our favor. Field team design. Buy or rent evaluation. Incentive compensation tied to the right behaviors. CRM the field actually uses.
Launch Readiness
You're 12–18 months from launch and the infrastructure doesn't exist yet.
Senior Expertise,
On Demand
You need a senior commercial voice in the room. Not after a six-month search.
We've carried what you're carrying. Oriented in days, not months. Decisive with incomplete information. Gone when you're running without us.
03
04
02
01
WHERE WE WORK WITH YOU
We meet you where the pressure is.
Our work is organized around the situations our clients face,
not the services we want to sell.
HOW WE WORK
How we show up
No lengthy onboarding. No methodology decks. Just experienced people getting oriented fast and focusing on what matters.
WE START BY LISTENING
We start with your situation, not a rote checklist.
We diagnose before we prescribe, each and every time.
01
WE WORK ALONGSIDE YOU
We work as part of your team, not above it.
Same room, same pressure, same accountability as your own people.
02
WE MOVE AT YOUR SPEED
We move at the speed your stage demands.
Oriented fast, decisive with incomplete information, no momentum lost.
03
WE STAY UNTIL IT WORKS
We see the work through without pause or hand-offs.
We execute relentlessly until the defined objectives are achieved.
04
THIS IS HOW WE THINK
We have opinions. Let's discuss.
Perspectives from practitioners who have been inside the challenges, not observing from the outside.
01
HEOR & Market Access
The problem isn't a lack of evidence ... it's a lack of direction on where effort should be targeted.
Break the Silos: How Early Integration of HEOR and Market Access Drives Commercial Success
Most biopharma companies engage HEOR and Market Access too late, then scramble after Phase 3 with evidence that doesn't resonate with payers.
This paper makes the case for designing evidence backward from payer needs, starting years before launch.
Coming Soon
Designing Patient-First Support Models
Coming Soon